Aller au contenu principal
Accès ouvert déclaré 2026 article

Opioid and Stimulant Coprescriptions among South Carolina Residents

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

OBJECTIVE: The South Carolina Department of Public Health (SCDPH) Prescription Drug Monitoring Program (PDMP) is used to monitor the prescribing patterns of controlled substances, including opioids and stimulants. Data collected by the National Center for Health Statistics show that the number of drug overdose deaths involving opioids and stimulants has been increasing since 1999. Although databases such as the PDMP monitor healthcare professionals' prescribing habits regarding opioids and stimulants individually, there has been little research regarding opioid-stimulant coprescribing patterns. Considering increasing death rates and the lack of research, data from the SCDPH PDMP were used to identify factors that influence opioid-stimulant coprescribing. It was hypothesized that younger age, higher daily morphine milligram milliequivalents (MMEs), increased duration of prescription, and male gender would be associated with increased opioid-stimulant coprescriptions. METHODS: Data were gathered from the SCDPH PDMP from 2016 to 2021. The variables assessed included patient age, patient sex, filling date, supply length, daily MMEs, and Lexicomp Drug Classification. A linear regression statistical analysis was then performed to analyze the data. RESULTS: <0.001). Being female (OR 1.58) and a daily MME ≥ 50 mg but ≤100 mg (OR 1.24) were both significantly found to indicate an increased odds of having a concurrent prescription. CONCLUSIONS: This study indicates that those with longer opioid prescriptions, younger individuals, higher daily MMEs, and women are at an increased risk of opioid-stimulant coprescription. Future research should investigate other factors associated with opioid-stimulant coprescribing, such as education status, rurality, and whether specific opioid or stimulant agents are linked to coprescribing.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Opioid and Stimulant Coprescriptions among South Carolina Residents
Date Crossref
01/09/2026
Éditeur
Southern Medical Association
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Opioid Use Disorder TreatmentPain Management and Opioid UseSubstance Abuse Treatment and Outcomes

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.